{"transactions":[{"id":758450,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:00:57.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001171843-26-003799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003799/ownership.xml","form_type":"4"}},{"id":1127248,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T01:29:54.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001171843-25-003592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003592/ownership.xml","form_type":"4"}},{"id":1824012,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:56:14.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009605","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009605/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824671,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:23.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009528","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009528/section16.xml","form_type":"4"}},{"id":3596684,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-03-13T23:35:25.000Z","date":"2019-03-12","kind":"grant","acquired":true,"shares":357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2020 and as to the remaining one-third on September 12, 2020."}],"balance_after":357,"derivative":{"exercise_price":1.25,"expiration_date":"2026-03-12","underlying":"Common Shares","underlying_shares":357},"source":{"system":"sec-edgar","filing":"0001144204-19-013778","document":"tv516186_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420419013778/tv516186_4.xml","form_type":"4"}},{"id":3995906,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-03-15T00:21:19.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019."}],"balance_after":2500,"derivative":{"exercise_price":0.84,"expiration_date":"2025-03-12","underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-18-014754","document":"tv488522_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420418014754/tv488522_4.xml","form_type":"4"}},{"id":4309708,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2017-05-22T20:45:16.000Z","date":"2017-05-20","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests monthly in 36 equal installments.  The vesting commencement date is May 20, 2019.  Vesting of 25% if this option shall be accelerated on interim data of 75% patients enrolled in the Company's RESULT Phase 3 clinical trial, whichever is earlier.  Following an acceleration of vesting of the options, the remaining unvested options shall vest in equal monthly installments through the remaining vesting period such that the entire award becomes fully vested 36 months from the vesting commencement date.  This option will expire on May 20, 2027."}],"balance_after":43750,"derivative":{"exercise_price":1.63,"expiration_date":"2027-05-20","underlying":"Common Stock","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001214659-17-003556","document":"marketforms-38874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316175/000121465917003556/marketforms-38874.xml","form_type":"4"}},{"id":4371285,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2017-03-27T21:02:16.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 23, 2018 and as to the remaining one-third on September 23, 2018."}],"balance_after":2500,"derivative":{"exercise_price":1.67,"expiration_date":"2024-03-23","underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-17-016845","document":"v462725_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420417016845/v462725_4.xml","form_type":"4"}},{"id":4466074,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Common Stock","published_at":"2017-02-06T18:33:40.000Z","date":"2017-01-11","kind":"grant","acquired":true,"shares":7767,"price":0.55,"value":4271.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents 7,767 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan for the offering period ended December 31, 2016."}],"balance_after":17519,"source":{"system":"sec-edgar","filing":"0001214659-17-000746","document":"marketforms-37769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1316175/000121465917000746/marketforms-37769.xml","form_type":"5"}},{"id":4466073,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Common Stock","published_at":"2017-02-06T18:33:40.000Z","date":"2016-06-30","kind":"grant","acquired":true,"shares":1789,"price":2.63,"value":4705.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 1,789 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan for the offering period ended June 30, 2016."}],"balance_after":9752,"source":{"system":"sec-edgar","filing":"0001214659-17-000746","document":"marketforms-37769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316175/000121465917000746/marketforms-37769.xml","form_type":"5"}},{"id":4513979,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2016-12-21T22:02:20.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third on December 20, 2017, as to one-third on December 20, 2018 and as to the remaining one-third on December 20, 2019."}],"balance_after":2500,"derivative":{"exercise_price":2.03,"expiration_date":"2023-12-20","underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-16-140714","document":"v455478_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420416140714/v455478_4.xml","form_type":"4"}}]}